Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2022 | Advances in immunotherapy for non-melanoma skin cancer

Paolo Ascierto, MD, National Tumor Institute Fondazione G. Pascale, Naples, Italy, discusses recent advances in immunotherapy for merkel cell carcinoma, cutaneous squamous cell carcinoma, and basal cell carcinoma. This interview took place at the European Society for Medical Oncology (ESMO) 2022 Congress in Paris, France.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.